Two exceptions to this observation were 2 patients whose IGF-I SDS levels remained above 2 and around −5 throughout Stage B. Possible explanations that were explored for these IGF-I SDS levels were acromegaly in the former and GH resistance in the latter, but this was not confirmed. This evidence concerns the gene IGF1 and acromegaly.